Merican University of Medical Genetics Marimastat Board of Directors: Points to take into consideration: ethical, authorized, and psychosocial implications of genetic testing in small children and adolescents. Am J Hum Genet 1995, fifty seven:1233?241. 102. Bernard R, Boyer A, Negre P, Malzac P, Latour P, Vandenberghe A, Philip N, Levy N: Prenatal detection from the 17p11.2 duplication in Charcot-MarieTooth sickness type 1A: requirement of a multidisciplinary tactic for heterogeneous diseases. Eur J Hum Genet 2002, 10:297?02. 103. Goossens V, Traeger-Synodinos J, Coonen E, De Rycke M, Moutou C, Pehlivan T, Derks-Smeets IA, Harton G: ESHRE PGD Consortium facts selection XI: cycles from January to December 2008 with being pregnant follow-up to Oct 2009. Hum Reprod 1887?911, 2012:27. 104. Harper JC, Wilton L, Traeger-Synodinos J, Goossens V, Moutou C, SenGupta SB, Pehlivan Budak T, Renwick P, De Rycke M, Geraedts JP, Harton G: The ESHRE PGD Consortium: 10 decades of data selection. Hum Reprod Update 2012, eighteen:234?47. 105. Younger P, De Jonghe P, Stogbauer F, Butterfass-Bahloul T: Cure for Charcot-Marie-Tooth disorder. Cochrane Database Syst Rev 2008, 1:CD006052. 106. Sackley C, Disler PB, Turner-Stokes L, Wade DT, Brittle N, Hoppitt T: Rehabilitation interventions for foot drop in neuromuscular condition. Cochrane Database Syst Rev 2009, three:CD003908. 107. Guyton GP, Mann RA: The pathogenesis and surgical administration of foot deformity in Charcot-Marie-Tooth illness. Foot Ankle Clin 2000, 5:317?26. 108. Ward CM, Dolan LA, Bennett DL, Morcuende JA, Cooper RR: Long-term outcomes of reconstruction for treatment of the flexible cavovarus foot in Charcot-Marie-Tooth disorder. J Bone Joint Surg Am 2008, 90:2631?642. 109. Leeuwesteijn AE, De Visser E, Louwerens JW: Adaptable cavovarus toes in Charcot-Marie-Tooth illness handled with 1st ray proximal dorsiflexion osteotomy coupled with gentle tissue surgical treatment: a short-term to mid-term end result examine. Foot Ankle Surg 2010, sixteen:142?47. one hundred ten. Videler A, Eijffinger E, Nollet F, Beelen A: A thumb opposition splint to boost handbook dexterity and upper-limb functioning in Charcot-MarieTooth disorder. J Rehabil Med 2012, 44:249?53. 111. Wooden VE, Huene D, Nguyen J: Treatment with the upper limb in CharcotMarie-Tooth disease. J Hand Surg [Br ] 1995, 20:511?18. 112. Brown RE, Zamboni WA, Zook EG, Russell RC: Evaluation and management of higher extremity neuropathies in Charcot- Marie-Tooth condition. J Hand Surg [Am ] 1992, 17:523?30. 113. Sheth S, Francies K, Siskind CE, Feely SM, Lewis RA, Shy ME: Diabetes mellitus exacerbates motor and sensory impairment in CMT1A. J Peripher Nerv Syst 2008, thirteen:299?04.114. Ursino G, Alberti MA, Grandis M, Reni L, Pareyson D, Bellone E, Gemelli C, Sabatelli M, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/22316373 Pisciotta C, Luigetti M, Santoro L, Massollo L, Schenone A: Impact of comorbidities within the phenotype of clients afflicted by Charcot-Marie-Tooth neuropathy type 1A. Neuromuscul Disord 2013, 23:902?06. 115. Weimer LH, Podwall D: Medication-induced exacerbation of neuropathy in Charcot Marie Tooth condition. J Neurol Sci 2006, 242:47?4. 116. Graf WD, Likelihood PF, Lensch MW, Eng LJ, Lipe HP, Hen TD: Extreme vincristine neuropathy in Charcot-Marie-Tooth condition form 1A. Cancer 1996, seventy seven:1356?362. 117. Hildebrandt G, Holler E, Woenkhaus M, Quarch G, Reichle A, Schalke B, Andreesen R: Acute deterioration of Charcot-Marie-Tooth ailment IA (CMT IA) adhering to two mg PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/9547713 of vincristine chemotherapy. Ann Oncol 2000, 11:743?47. 118. Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDerm.